TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof. November 30, 2001
TCL Archive Freestanding Cancer Centers May Be The “Missing Ingredient In Cancer Treatment,” DeVita Believes January 11, 1985
